Trial · NCT00278512
Hematopoietic Stem Cell Support in Vasculitis
NCT00278512, Phase 1, Terminated, Northwestern University; results first posted 2018-08-02
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Hematopoietic Stem Cell Support in Vasculitis. Trials, record NCT00278512. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00278512
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Hematopoietic Stem Cell Support in Vasculitis
- NCT number
- NCT00278512
- Status
- Terminated
- Phases
- Phase 1
- Enrollment
- 7 participants, actual
- Lead sponsor
- Northwestern University
- Conditions
- Vasculitis
- Interventions
- Autologous Stem Cell Transplant, Allogeneic Stem Cell Transplant, Cyclophosphamide, ATG (rabbit), G-CSF, Campath-1h, Fludarabine, Tacrolimus, Mesna
- First posted
- 2006-01-18
- Last updated
- 2018-08-02
- Results first posted
- 2018-08-02
- Limitations and caveats
- Small numbers of subjects enrolled
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Survival | Up to 5 years | Survival |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Survival | Up to 5 years | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Survival | Autologous Stem Cell Transplant | 6 | Participants | ||
| Survival | Allogeneic Stem Cell Transplant | 0 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Autologous Stem Cell Transplant | 7 | |
| Overall Study | STARTED | Allogeneic Stem Cell Transplant | 0 | |
| Overall Study | COMPLETED | Autologous Stem Cell Transplant | 6 | |
| Overall Study | COMPLETED | Allogeneic Stem Cell Transplant | 0 | |
| Overall Study | NOT COMPLETED | Autologous Stem Cell Transplant | 1 | |
| Overall Study | NOT COMPLETED | Allogeneic Stem Cell Transplant | 0 |
Source ClinicalTrials.gov
Adverse events14
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Swine flu | Infections and infestations | Autologous Stem Cell Transplant | 1 | 7 | 1 |
| other | Swine flu | Infections and infestations | Allogeneic Stem Cell Transplant | 0 | 0 | 0 |
| other | Aspergillus | Infections and infestations | Autologous Stem Cell Transplant | 1 | 7 | 1 |
| other | Aspergillus | Infections and infestations | Allogeneic Stem Cell Transplant | 0 | 0 | 0 |
| other | Pseudomonas pneumonia | Infections and infestations | Autologous Stem Cell Transplant | 1 | 7 | 1 |
| other | Pseudomonas pneumonia | Infections and infestations | Allogeneic Stem Cell Transplant | 0 | 0 | 0 |
| other | bowel obstruction | Gastrointestinal disorders | Autologous Stem Cell Transplant | 1 | 7 | 1 |
| other | bowel obstruction | Gastrointestinal disorders | Allogeneic Stem Cell Transplant | 0 | 0 | 0 |
| other | Pulmonary Embolus | Cardiac disorders | Autologous Stem Cell Transplant | 1 | 7 | 1 |
| other | Pulmonary Embolus | Cardiac disorders | Allogeneic Stem Cell Transplant | 0 | 0 | 0 |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 adverse eventsAdverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Autologous Stem Cell Transplant | 1 | 7 |
| Total, all-cause mortality | Allogeneic Stem Cell Transplant | 0 | 0 |
| Total, other adverse events | Autologous Stem Cell Transplant | 2 | 7 |
| Total, other adverse events | Allogeneic Stem Cell Transplant | 0 | 0 |
| Total, serious adverse events | Autologous Stem Cell Transplant | 1 | 7 |
| Total, serious adverse events | Allogeneic Stem Cell Transplant | 0 | 0 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00278512
GET https://conductscience.org/api/trials/v1/NCT00278512/registered